articleEuropean Journal of CancerApr 12, 2016Closed access

Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy

University of Duisburg-Essen · University Hospital of Zurich · +16 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

560
total citations
FWCI
41.66
Percentile
100%
References
34
Citations per year

Authors

28

Topics & keywords

Keywords
  • Medicine
  • Nivolumab
  • Pembrolizumab
  • Ipilimumab
  • Side effect (computer science)
  • Adverse effect
  • Cancer
  • Myasthenia gravis
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding